G8J-25837-17583 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-25
Registered in v-safe
2021-02-25
Dose 1 — Pfizer-BioNTech
2021-02-25
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-02-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-18
Dose 2 — Pfizer-BioNTech
2021-03-18
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-09-16
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-11
Dose 3 — Pfizer-BioNTech
2022-03-18
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-05-12
Survey response — 6 months, dose 3
MedDRA: Nasopharyngitis — Feeling: Good

Free text: Cold

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-25	Pfizer-BioNTech
2	2021-03-18	Pfizer-BioNTech
3	2021-11-11	Pfizer-BioNTech	No

Free text

Release 11 — 6 months, dose 3

2022-05-12

Symptoms: Cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release